Last reviewed · How we verify

Lipid Emulsion, Intravenous

Aya Sabry Mohamed Mohamed · FDA-approved active Small molecule

Lipid Emulsion, Intravenous is a Parenteral nutrition supplement Small molecule drug developed by Aya Sabry Mohamed Mohamed. It is currently FDA-approved for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Source of essential fatty acids and calories in critical illness, post-operative states, and malabsorption.

Lipid emulsion provides essential fatty acids and calories intravenously by delivering a mixture of lipids in an emulsified form for parenteral nutrition.

Lipid emulsion provides essential fatty acids and calories intravenously by delivering a mixture of lipids in an emulsified form for parenteral nutrition. Used for Parenteral nutrition in patients unable to maintain adequate oral or enteral intake, Prevention of essential fatty acid deficiency in long-term parenteral nutrition, Caloric supplementation in critically ill or post-operative patients.

At a glance

Generic nameLipid Emulsion, Intravenous
SponsorAya Sabry Mohamed Mohamed
Drug classParenteral nutrition supplement
ModalitySmall molecule
Therapeutic areaNutrition support / Critical care
PhaseFDA-approved

Mechanism of action

Intravenous lipid emulsion is a sterile, injectable formulation containing triglycerides (typically soybean or fish oil-based) suspended in water with emulsifying agents. It serves as a source of energy and essential fatty acids for patients unable to receive adequate nutrition orally or enterally, supporting cellular function and reducing protein catabolism.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lipid Emulsion, Intravenous

What is Lipid Emulsion, Intravenous?

Lipid Emulsion, Intravenous is a Parenteral nutrition supplement drug developed by Aya Sabry Mohamed Mohamed, indicated for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Source of essential fatty acids and calories in critical illness, post-operative states, and malabsorption.

How does Lipid Emulsion, Intravenous work?

Lipid emulsion provides essential fatty acids and calories intravenously by delivering a mixture of lipids in an emulsified form for parenteral nutrition.

What is Lipid Emulsion, Intravenous used for?

Lipid Emulsion, Intravenous is indicated for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Source of essential fatty acids and calories in critical illness, post-operative states, and malabsorption.

Who makes Lipid Emulsion, Intravenous?

Lipid Emulsion, Intravenous is developed and marketed by Aya Sabry Mohamed Mohamed (see full Aya Sabry Mohamed Mohamed pipeline at /company/aya-sabry-mohamed-mohamed).

What drug class is Lipid Emulsion, Intravenous in?

Lipid Emulsion, Intravenous belongs to the Parenteral nutrition supplement class. See all Parenteral nutrition supplement drugs at /class/parenteral-nutrition-supplement.

What development phase is Lipid Emulsion, Intravenous in?

Lipid Emulsion, Intravenous is FDA-approved (marketed).

What are the side effects of Lipid Emulsion, Intravenous?

Common side effects of Lipid Emulsion, Intravenous include Hypertriglyceridemia, Lipemia, Phlebitis at infusion site, Allergic reactions, Hepatic dysfunction.

Related